Home    Resource Store    Past Issues    Buyers' Guide    Career Center    Subscriptions    Advertising    E-Newsletter    Contact

Textile World Photo Galleries
November/December 2015 November/December 2015

View Issue  |

Subscribe Now  |


From Farm To Fabric: The Many Faces Of Cotton - The 74th Plenary Meeting of the International Cotton Advisory Committee (ICAC)
12/06/2015 - 12/11/2015

Capstone Course On Nonwoven Product Development
12/07/2015 - 12/11/2015

2nd Morocco International Home Textiles & Homewares Fair
03/16/2016 - 03/19/2016

- more events -

- submit your event -

Printer Friendly
Full Site
Textile News

Genencor Acquires Exclusive License To Ecolab Patents For Denim Stonewashing In Europe

ROCHESTER, N.Y., June 18 /PRNewswire/ --Genencor International, Inc. (Nasdaq: GCOR) announced today it has acquired an exclusive license to Ecolab Inc.'s (NYSE: ECL) Stone-Eze(R) patents for use throughout Europe. The patents broadly cover processes for producing astone-washed effect in denim or other cellulosic fabrics using cellulase. Genencor's patent exclusivity means its cellulase enzymes are the only products licensed for use throughout Europe in the stone washing process for denim and other cellulosic fabrics. Genencor IndiAge(R) and Primafast(R)cellulase enzymes and enzyme compositions, used to create a stone-washed appearance to cellulosic fabrics or garments, are covered under the agreement. "We estimate that the world wide market for textile enzymes is in excess of $125 million of which the majority is for the cellulase business segment,"said Tom Pekich, group vice president of Industrial Chemicals for Genencor."Acquiring an exclusive license to the European Stone-Eze patents gives us a strategic competitive asset in the textile marketplace." According to an independent market research study conducted last year by Werner International, over 200 million denim jeans were sold in Europe during1999. Consumer demand was highest in France, Germany, Italy, Spain, and the United Kingdom. About Genencor Genencor International is a diversified biotechnology company that develops and delivers innovative products into the health care, agriculture and industrial chemicals markets. Using an integrated set of technology platforms, Genencor's products deliver innovative and sustainable solutions to many of the problems of everyday life. Genencor was established in 1982 as a joint venture between Genentech Inc.and Corning Incorporated. Since its founding, Genencor has grown to become a leading biotechnology company, with over $315 million in annual revenues, more than 250 biotechnology products in commerce, and over 3,400 owned and licensed patents and applications. Genencor, with more than 1,500 employees worldwide,has principal offices in Palo Alto, California; Rochester, New York; andLeiden, the Netherlands.About Ecolab Ecolab is the leading global developer and marketer of premium cleaning,sanitizing, pest elimination, maintenance and repair products and services forthe hospitality, institutional and industrial markets. Except for the historical information contained herein, the matters discussed in this press release may contain forward-looking statements which involve risks and uncertainties, including significant fluctuations in product performance depending on factors such as a dependence on the efforts of third parties, a new and uncertain technology employed by Genencor and its uncertain application to new business ventures, dependence on intellectual propert yrights, the competitive nature of Genencor's industry and risks of obsolescence of certain technology. Actual results may differ materially from those projected. Forward-looking statements represent the judgment of Genencoras of the date of this release. Genencor disclaims, however, any intent or obligation to update any forward-looking statements.SOURCE Genencor International, Inc.Web Site: http://www.genencor.comCopyright 2001 PR Newswire